Found: 68
Select item for more details and to access through your institution.
Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[<sup>18</sup>F]FMeNER-D<sub>2</sub>.
- Published in:
- International Journal of Neuropsychopharmacology, 2017, v. 20, n. 12, p. 957, doi. 10.1093/ijnp/pyx069
- By:
- Publication type:
- Article
Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
- Published in:
- International Journal of Neuropsychopharmacology, 2017, v. 20, n. 11, p. 928, doi. 10.1093/ijnp/pyx063
- By:
- Publication type:
- Article
Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[<sup>18</sup>F]FMeNER-D<sub>2</sub>.
- Published in:
- International Journal of Neuropsychopharmacology, 2014, v. 17, n. 4, p. 553, doi. 10.1017/S1461145713001521
- By:
- Publication type:
- Article
Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [11C]DASB and (S,S)-[18F]FMeNER-D2.
- Published in:
- International Journal of Neuropsychopharmacology, 2013, v. 16, n. 5, p. 937, doi. 10.1017/S1461145712001009
- By:
- Publication type:
- Article
Parametric identification of the joint distribution of the potential outcomes.
- Published in:
- Stat, 2020, v. 9, n. 1, p. 1, doi. 10.1002/sta4.254
- By:
- Publication type:
- Article
Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder.
- Published in:
- Translational Psychiatry, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41398-024-03107-3
- By:
- Publication type:
- Article
PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2023, v. 49, n. 3, p. 688, doi. 10.1093/schbul/sbac181
- By:
- Publication type:
- Article
Involvement of differential tau pathologies in late‐onset bipolar disorder assessed by PET with <sup>18</sup>F‐florzolotau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078062
- By:
- Publication type:
- Article
The aftermath of boxing: Longitudinal changes of cerebral retention patterns of <sup>18</sup>F‐florzolotau (<sup>18</sup>F‐APN‐1607) in the former professional boxers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076455
- By:
- Publication type:
- Article
In vivo characterization of tau accumulation in patients with frontotemporal dementia: A PET study with <sup>18</sup>F‐florzolotau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078492
- By:
- Publication type:
- Article
Development and Comparison of a Novel Mid‐Region Directed p‐Tau 181 Assay with Tau Positron Emission Tomography in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078621
- By:
- Publication type:
- Article
Rightward lateralization of frontal cortex tau pathologies is associated with late‐onset psychosis: A PET study with <sup>18</sup>F‐PM‐PBB3.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.065288
- By:
- Publication type:
- Article
Altered brain energy metabolism related to astrocytes in tauopathies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.059834
- By:
- Publication type:
- Article
Amyloid status prediction by combining plasma p‐tau181 and NfL cut‐offs.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.062035
- By:
- Publication type:
- Article
Utility evaluation and radio‐pathological analysis of a tau tracer, <sup>18</sup>F‐PI‐2620, in Alzheimer's disease (AD) and non‐AD tauopathies: Neuroimaging / New imaging methods.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041735
- By:
- Publication type:
- Article
A tau PET study of primary age‐related tauopathy in healthy volunteers: Neuroimaging / Normal brain aging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041730
- By:
- Publication type:
- Article
Grouping tau topologies in former boxers assessed by PET with <sup>18</sup>F‐PM‐PBB3: A reappraisal of dementia pugilistica: Neuroimaging / Optimal neuroimaging measures for tracking disease progression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041510
- By:
- Publication type:
- Article
P4‐586: CLINICAL CHARACTERIZATION OF [<sup>18</sup>F]PM‐PBB3 IN THE BRAINS OF MILD‐REPETITIVE TRAUMATIC BRAIN INJURY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1546, doi. 10.1016/j.jalz.2019.08.134
- By:
- Publication type:
- Article
P3‐380: CLINICAL CHARACTERIZATION OF <sup>18</sup>F‐PI2620 IN ALZHEIMER'S DISEASE AND OTHER TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1093, doi. 10.1016/j.jalz.2019.06.3413
- By:
- Publication type:
- Article
P3‐363: IN VIVO RETENTION PATTERNS OF <sup>18</sup>F‐PI‐2620 IN DIVERSE TAUOPATHIES, AND ASSESSMENTS OF THOSE RESEMBLANCE TO PATHOGNOMONIC DISTRIBUTION OF TAU DEPOSITS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1085, doi. 10.1016/j.jalz.2019.06.3396
- By:
- Publication type:
- Article
P2‐382: IN VIVO TRACKING OF TAU PATHOLOGIES WITH <sup>18</sup>F‐PM‐PBB3 (<sup>18</sup>F‐APN‐1607) PET IN AD AND DIVERSE NON‐AD TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P749, doi. 10.1016/j.jalz.2019.06.2789
- By:
- Publication type:
- Article
IC‐P‐179: IN VIVO TRACKING OF TAU PATHOLOGIES WITH <sup>18</sup>F‐PM‐PBB3 (<sup>18</sup>F‐APN‐1607) PET IN AD AND DIVERSE NON‐AD TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P140, doi. 10.1016/j.jalz.2019.06.4294
- By:
- Publication type:
- Article
IC‐P‐179: IN VIVO TRACKING OF TAU PATHOLOGIES WITH <sup>18</sup>F‐PM‐PBB3 (<sup>18</sup>F‐APN‐1607) PET IN AD AND DIVERSE NON‐AD TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P140, doi. 10.1016/j.jalz.2019.06.4294
- By:
- Publication type:
- Article
P1‐125: PRECLINICAL AND CLINICAL CHARACTERIZATION OF <sup>18</sup>F‐PM‐PBB3, A PET LIGAND FOR DIVERSE TAU PATHOLOGIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P318, doi. 10.1016/j.jalz.2018.06.128
- By:
- Publication type:
- Article
IC‐P‐221: TAU ACCUMULATION PREDICTS PROGRESSION OF DEMENTIA IN SUBJECTS WITH EARLY ALZHEIMER'S DISEASE IN THE ALZHEIMER'S DISEASE SPECTRUM: A [<sup>11</sup>C]PBB3 POSITRON EMISSION TOMOGRAPHY STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P180, doi. 10.1016/j.jalz.2018.06.2288
- By:
- Publication type:
- Article
IC‐P‐217: PRECLINICAL AND CLINICAL CHARACTERIZATION OF <sup>18</sup>F‐PM‐PBB3, A PET LIGAND FOR DIVERSE TAU PATHOLOGIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P177, doi. 10.1016/j.jalz.2018.06.2284
- By:
- Publication type:
- Article
Relationship between regional gray matter volumes and dopamine D<sub>2</sub> receptor and transporter in living human brains.
- Published in:
- Human Brain Mapping, 2021, v. 42, n. 12, p. 4048, doi. 10.1002/hbm.25538
- By:
- Publication type:
- Article
FIRST-IN-HUMAN PET STUDY WITH 18F-AM-PBB3 AND 18F-PM-PBB3.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P146, doi. 10.1016/j.jalz.2017.06.2573
- By:
- Publication type:
- Article
FIRST-IN-HUMAN PET STUDY WITH 18F-AM-PBB3 AND 18F-PM-PBB3.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1104, doi. 10.1016/j.jalz.2017.06.1594
- By:
- Publication type:
- Article
Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series.
- Published in:
- Psychiatry & Clinical Neurosciences Reports, 2024, v. 3, n. 1, p. 1, doi. 10.1002/pcn5.178
- By:
- Publication type:
- Article
It's Not My Fault: Postdictive Modulation of Intentional Binding by Monetary Gains and Losses.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0053421
- By:
- Publication type:
- Article
Effects of Dopamine D<sub>2</sub> Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-<sup>11</sup>C]DOPA.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0046488
- By:
- Publication type:
- Article
Increased left anterior insular and inferior prefrontal activity in post-stroke mania.
- Published in:
- BMC Neurology, 2012, v. 12, n. 1, p. 68, doi. 10.1186/1471-2377-12-68
- By:
- Publication type:
- Article
Dynamic alterations in the central glutamatergic status following food and glucose intake: in vivo multimodal assessments in humans and animal models.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 11, p. 2928, doi. 10.1177/0271678X211004150
- By:
- Publication type:
- Article
Successful treatment of dopamine dysregulation syndrome with dopamine D<sub>2</sub> partial agonist antipsychotic drug.
- Published in:
- Annals of General Psychiatry, 2012, v. 11, n. 1, p. 19, doi. 10.1186/1744-859X-11-19
- By:
- Publication type:
- Article
[C]TASP457, a novel PET ligand for histamine H receptors in human brain.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 9, p. 1653, doi. 10.1007/s00259-016-3332-6
- By:
- Publication type:
- Article
A human PET study of [C]HMS011, a potential radioligand for AMPA receptors.
- Published in:
- EJNMMI Research, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13550-017-0313-0
- By:
- Publication type:
- Article
Striatal and extrastriatal dopamine D receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [C]raclopride and [C]FLB457.
- Published in:
- Psychopharmacology, 2012, v. 222, n. 1, p. 165, doi. 10.1007/s00213-011-2633-5
- By:
- Publication type:
- Article
Case report: Non-Alzheimer's disease tauopathy with logopenic variant primary progressive aphasia diagnosed using amyloid and tau PET.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.1049113
- By:
- Publication type:
- Article
PET Quantification of the Norepinephrine Transporter in Human Brain with (S,S)-<sup>18</sup>F-FMeNER-D<sub>2</sub>.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1140, doi. 10.2967/jnumed.116.178913
- By:
- Publication type:
- Article
Quantitative Analysis of Amyloid Deposition in Alzheimer Disease Using PET and the Radiotracer <sup>11</sup>C-AZD2184.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 6, p. 932, doi. 10.2967/jnumed.113.133793
- By:
- Publication type:
- Article
Quantification of Dopamine Transporter in Human Brain Using PET with <sup>18</sup>F-FE-PE2I.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 7, p. 1065, doi. 10.2967/jnumed.111.101626
- By:
- Publication type:
- Article
Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects.
- Published in:
- Annals of Nuclear Medicine, 2023, v. 37, n. 5, p. 300, doi. 10.1007/s12149-023-01828-x
- By:
- Publication type:
- Article
In vivo PET classification of tau pathologies in patients with frontotemporal dementia.
- Published in:
- Brain Communications, 2024, v. 6, n. 2, p. 1, doi. 10.1093/braincomms/fcae075
- By:
- Publication type:
- Article
Evaluation of [<sup>18</sup>F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies.
- Published in:
- Brain Communications, 2021, v. 3, n. 4, p. 1, doi. 10.1093/braincomms/fcab190
- By:
- Publication type:
- Article
Findings of <sup>18</sup>F‐PI‐2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P‐tau181 levels in a Japanese sample.
- Published in:
- Neuropsychopharmacology Reports, 2022, v. 42, n. 4, p. 437, doi. 10.1002/npr2.12281
- By:
- Publication type:
- Article
Binding of Dopamine D<sub>1</sub> Receptor and Noradrenaline Transporter in Individuals with Autism Spectrum Disorder: A PET Study.
- Published in:
- Cerebral Cortex, 2020, v. 30, n. 12, p. 6458, doi. 10.1093/cercor/bhaa211
- By:
- Publication type:
- Article
In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 2, p. 247, doi. 10.1002/ana.26962
- By:
- Publication type:
- Article